Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Venture Funding Deals: $688.8m In Financings From Avitide To Zai Lab

Executive Summary

June venture capital financings for emerging companies totaled more than $688.8m, ranging from an undisclosed round for Avitide to a $120m Series B for Rubius Therapeutics.

Advertisement

Related Content

Melinta To Launch First Commercial Drug Baxdela Independently
Finance Watch: Summer Slowdown Begins Ahead Of BIO, But Two IPOs Launched
Deal Watch: Array Partners With Ono On Cancer Drugs In Japan, South Korea
FINANCE ROUNDUP: Will VC Be Last Man Standing If Biotech Bubble Bursts?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC099101

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel